{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:29:34Z","timestamp":1773502174087,"version":"3.50.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Comenius University Bratislava 2024","award":["UK\/3096\/2024"],"award-info":[{"award-number":["UK\/3096\/2024"]}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["APVV-23-0502"],"award-info":[{"award-number":["APVV-23-0502"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>In diabetes mellitus, inflammation and apoptosis contribute to cardiovascular injury and oxidative damage. Dapagliflozin and Pio, beyond their hypoglycemic effects, mitigate organ damage. This study explored whether their combination provides enhanced protection against cardiac damage in streptozotocin-induced diabetic rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Wistar rats were divided into control, diabetic (STZ, 55\u00a0mg\/kg, i.p.), dapagliflozin-treated (10\u00a0mg\/kg, chow), pioglitazone-treated (12\u00a0mg\/kg, chow), and combination groups. After six weeks, systolic blood pressure, glucose, and lipids were assessed; subsequently, the left ventricle was excised for real-time quantitative PCR and western blot analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Both drugs alleviated STZ-induced weight loss, water intake, and urine output without significant glucose reduction. The monotherapy also effectively modulated oxidative stress, inflammation, and apoptosis. The combination of drugs led to a more favourable lipid profile than the individual drugs. Dapagliflozin + pioglitazone additively upregulated MnSOD, normalized Bcl2 and Bax\/Bcl2 ratios, and decreased tumour necrosis factor-\u03b1 levels in the left ventricle. These effects were associated with improved cardiac damage markers (Myh6\/Myh7 ratio) and systolic blood pressure compared to the administration of the drugs alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined dapagliflozin and pioglitazone protect diabetic rat hearts by reducing oxidative stress, inflammation, and apoptosis, independently of glycemic control. This combination therapy offers a promising approach to mitigate cardiovascular complications in diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgaf091","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:56:20Z","timestamp":1757505380000},"source":"Crossref","is-referenced-by-count":2,"title":["Additive cardioprotection by dapagliflozin and pioglitazone co-therapy in streptozotocin-induced diabetic rats"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8993-9011","authenticated-orcid":false,"given":"Eva","family":"Kralova","sequence":"first","affiliation":[{"name":"Comenius University Bratislava , Faculty of Pharmacy, Department of Pharmacology and Toxicology, SK-83232 Bratislava,","place":["Slovakia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Cinakova","sequence":"additional","affiliation":[{"name":"Comenius University Bratislava , Faculty of Pharmacy, Department of Pharmacology and Toxicology, SK-83232 Bratislava,","place":["Slovakia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Klimas","sequence":"additional","affiliation":[{"name":"Comenius University Bratislava , Faculty of Pharmacy, Department of Pharmacology and Toxicology, SK-83232 Bratislava,","place":["Slovakia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-2732","authenticated-orcid":false,"given":"Peter","family":"Krenek","sequence":"additional","affiliation":[{"name":"Comenius University Bratislava , Faculty of Pharmacy, Department of Pharmacology and Toxicology, SK-83232 Bratislava,","place":["Slovakia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2026012010265958800_ref1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/J.BIOPHA.2018.11.086","article-title":"Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate","volume":"109","author":"Al Hroob","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026012010265958800_ref2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/jpp\/rgac019","article-title":"Anti-inflammatory, anti-oxidant and anti-apoptotic effects of olive leaf extract in cardiac tissue of diabetic rats","volume":"74","author":"Asghari","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"2026012010265958800_ref3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.niox.2014.08.004","article-title":"Nitric oxide synthases and diabetic cardiomyopathy","volume":"43","author":"Khanna","year":"2014","journal-title":"Nitric Oxide"},{"key":"2026012010265958800_ref4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.yjmcc.2006.07.006","article-title":"Regulating the regulator: NF-kappaB signalling in heart","volume":"41","author":"Hall","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2026012010265958800_ref5","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1210\/en.2006-0728","article-title":"Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes","volume":"147","author":"Aragno","year":"2006","journal-title":"Endocrinology"},{"key":"2026012010265958800_ref6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.imlet.2004.07.012","article-title":"Chronic exercise and the pro-inflammatory response to endotoxin in the serum and heart","volume":"95","author":"Criswell","year":"2004","journal-title":"Immunol Lett"},{"key":"2026012010265958800_ref7","first-page":"213","article-title":"Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart","volume":"10","author":"Saini","year":"2005","journal-title":"Exp Clin Cardiol"},{"key":"2026012010265958800_ref8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"2026012010265958800_ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2198645","article-title":"Peroxisome proliferator-activated receptor-\u03b3 is critical to cardiac fibrosis","volume":"2016","author":"Liu","year":"2016","journal-title":"PPAR Res"},{"key":"2026012010265958800_ref10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective Pio clinical trial in macroVascular events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"2026012010265958800_ref11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/nejmoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012010265958800_ref12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1159\/000533592","article-title":"Adding SGLT2 cotransporter inhibitor to PPAR\u03b3 activator does not provide an additive effect in the Management of Diabetes-Induced Vascular Dysfunction","volume":"108","author":"Cinakova","year":"2023","journal-title":"Pharmacology"},{"key":"2026012010265958800_ref13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000341770","article-title":"Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients","volume":"22","author":"Yu","year":"2013","journal-title":"Med Princ Pract"},{"key":"2026012010265958800_ref14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.diabres.2007.04.012","article-title":"Effect of pioglitazone therapy in lean type1 diabetes mellitus","volume":"78","author":"Bhat","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2026012010265958800_ref15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11897-017-0340-1","article-title":"Role of SGLT2 inhibitors in patients with diabetes mellitus and heart failure","volume":"14","author":"Verbrugge","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"2026012010265958800_ref16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2147\/TCRM.S275076","article-title":"The role of dapagliflozin in the management of heart failure: an update on the emerging evidence","volume":"Volume 17","author":"Gupta","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"2026012010265958800_ref17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012010265958800_ref18","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"2026012010265958800_ref19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"2026012010265958800_ref20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/JOE-17-0457","article-title":"Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury","volume":"236","author":"Tanajak","year":"2018","journal-title":"J Endocrinol"},{"key":"2026012010265958800_ref21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejmech.2014.11.041","article-title":"Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents","volume":"90","author":"Sharma","year":"2015","journal-title":"European Jornal of Medicinal Chemistry"},{"key":"2026012010265958800_ref22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1039\/c7fo01460k","article-title":"Anti-diabetic activity of a polyphenol-rich extract from Phellinus igniarius in KK-ay mice with spontaneous type 2 diabetes mellitus","volume":"9","author":"Zheng","year":"2018","journal-title":"Food Funct"},{"key":"2026012010265958800_ref23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jnutbio.2015.12.020","article-title":"Purple rice anthocyanin extract protects cardiac function in STZ-induced diabetes rat hearts by inhibiting cardiac hypertrophy and fibrosis","volume":"31","author":"Chen","year":"2016","journal-title":"J Nutr Biochem"},{"key":"2026012010265958800_ref24","doi-asserted-by":"publisher","first-page":"e0125603","DOI":"10.1371\/journal.pone.0125603","article-title":"Effect of sodium-glucose cotransport inhibition on polycystic kidney disease progression in PCK rats","volume":"10","author":"","year":"2015","journal-title":"PLoS One"},{"key":"2026012010265958800_ref25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2014.02.023","article-title":"Pioglitazone, a PPAR\u03b3 agonist, provides comparable protection to the angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat","volume":"730","author":"Ochodnicky","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2026012010265958800_ref26","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2026012010265958800_ref27","doi-asserted-by":"publisher","first-page":"162724","DOI":"10.1155\/2013\/162724","article-title":"Antihyperglycemic effect of ginkgo biloba extract in streptozotocin-induced diabetes in rats","volume":"2013","author":"Cheng","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026012010265958800_ref28","doi-asserted-by":"publisher","first-page":"24057","DOI":"10.1074\/jbc.M704574200","article-title":"Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart","volume":"282","author":"Krenz","year":"2007","journal-title":"J Biol Chem"},{"key":"2026012010265958800_ref29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1023\/B:MCBI.0000028765.89855.73","article-title":"Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes","volume":"261","author":"Machackova","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"2026012010265958800_ref30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00210-020-01979-y","article-title":"Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII\/NF-\u03baB\/TGF-\u03b21 and PPAR-\u03b3 signaling pathway","volume":"394","author":"Gbr","year":"2021","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"2026012010265958800_ref31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1139\/cjpp-2015-0135","article-title":"Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis","volume":"94","author":"Khodeer","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"2026012010265958800_ref32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/MAJ.0b013e31816b874b","article-title":"Brain natriuretic peptide in cardiovascular diseases","volume":"335","author":"Synetos","year":"2008","journal-title":"Am J Med Sci"},{"key":"2026012010265958800_ref33","doi-asserted-by":"publisher","first-page":"065","DOI":"10.1385\/cbb:44:1:065","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia","volume":"44","author":"Makino","year":"2006","journal-title":"Cell Biochem Biophys"},{"key":"2026012010265958800_ref34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-021-01294-7","article-title":"Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug","volume":"20","author":"Nesti","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2026012010265958800_ref35","doi-asserted-by":"publisher","first-page":"708177","DOI":"10.3389\/fphar.2021.708177","article-title":"A SGLT2 inhibitor dapagliflozin alleviates diabetic cardiomyopathy by suppressing high glucose-induced oxidative stress in vivo and in vitro","volume":"12","author":"Xing","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026012010265958800_ref36","doi-asserted-by":"publisher","first-page":"H1728","DOI":"10.1152\/ajpheart.01328.2005","article-title":"Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine","volume":"292","author":"Guo","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012010265958800_ref37","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ceb.2009.08.005","article-title":"Mitochondrial reactive oxygen species regulate hypoxic signaling","volume":"21","author":"Hamanaka","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"2026012010265958800_ref38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium\u2013glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012010265958800_ref39","doi-asserted-by":"publisher","first-page":"e00239","DOI":"10.1002\/prp2.239","article-title":"Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice","volume":"4","author":"Hatanaka","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"2026012010265958800_ref40","doi-asserted-by":"publisher","first-page":"590541","DOI":"10.1155\/2014\/590541","article-title":"Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice","volume":"2014","author":"Takahashi","year":"2014","journal-title":"J Diabetes Res"},{"key":"2026012010265958800_ref41","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/j.1476-5381.2012.01938.x","article-title":"Submaximal PPAR\u03b3 activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders","volume":"166","author":"Balakumar","year":"2012","journal-title":"Kathuria, Sonan"},{"key":"2026012010265958800_ref42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/dmrr.379","article-title":"Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts\u2014comparison of the effects of pioglitazone and metformin","volume":"19","author":"Kawabata","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"2026012010265958800_ref43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1139\/cjpp-2022-0045","article-title":"The effect of dapagliflozin on myocardial ischemia\u2013reperfusion injury in diabetic rats","volume":"101","author":"Xiong","year":"2023","journal-title":"Can J Physiol Pharmacol"},{"key":"2026012010265958800_ref44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.fct.2013.11.013","article-title":"Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis","volume":"63","author":"Sun","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"2026012010265958800_ref45","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/molecules21091248","article-title":"Asiatic acid attenuates myocardial ischemia\/reperfusion injury via Akt\/GSK-3\u03b2\/HIF-1\u03b1 signaling in rat H9c2 cardiomyocytes","volume":"21","author":"Huang","year":"2016","journal-title":"Molecules"},{"key":"2026012010265958800_ref46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.yjmcc.2009.07.024","article-title":"Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity","volume":"47","author":"Yoshida","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2026012010265958800_ref47","first-page":"2101","article-title":"Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2","volume":"15","author":"Produit-Zengaffinen","year":"2009","journal-title":"Mol Vis"},{"key":"2026012010265958800_ref48","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies","volume":"9","author":"Borghetti","year":"2018","journal-title":"Beyond glycemic control Front Physiol"},{"key":"2026012010265958800_ref49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6091\/ibj.1366.2015","article-title":"Is Bax\/Bcl-2 ratio considered as a prognostic marker with age and tumor location in colorectal cancer?","volume":"19","author":"Khodapasand","year":"2015","journal-title":"Iran Biomed J"},{"key":"2026012010265958800_ref50","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1159\/000475942","article-title":"The sodium-glucose co-transporter 2 inhibitor, empagliflozin, protects against diabetic cardiomyopathy by inhibition of the endoplasmic reticulum stress pathway","volume":"41","author":"Zhou","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026012010265958800_ref51","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1536\/ihj.21-404","article-title":"Pioglitazone protects against hypoxia-induced cardiomyocyte apoptosis through inhibiting NLRP3\/Caspase-1 pathway in vivo and in vitro","volume":"63","author":"Zhang","year":"2022","journal-title":"Int Heart J"},{"key":"2026012010265958800_ref52","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"2026012010265958800_ref53","doi-asserted-by":"publisher","first-page":"a00165","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"2026012010265958800_ref54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with Saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026012010265958800_ref55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/eurheartj\/ehad655.2682","article-title":"SGLT2 i dapagliflozin reduces NF-kB expression in heart and kydneys of preclinical models exposed to doxorubicin through MYd-88 and NLRP3 pathways: an hystological study","volume":"44","author":"Maurea","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012010265958800_ref56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol"},{"key":"2026012010265958800_ref57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2011.04.038","article-title":"Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia\/reperfusion injury in rats","volume":"663","author":"Ahmed","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2026012010265958800_ref58","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fphar.2020.00730","article-title":"Peroxisome proliferator-activated receptors: experimental targeting for the treatment of inflammatory bowel diseases","volume":"11","author":"Decara","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026012010265958800_ref59","doi-asserted-by":"publisher","first-page":"e10782","DOI":"10.1590\/1414-431X2020E10782","article-title":"The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance","volume":"54","author":"Al-Muzafar","year":"2021","journal-title":"Braz J Med Biol Res"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/1\/rgaf091\/64426916\/rgaf091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/1\/rgaf091\/64426916\/rgaf091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:27:08Z","timestamp":1768922828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgaf091\/8267825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaf091","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,29]]},"article-number":"rgaf091"}}